NCT01544634View on ClinicalTrials.gov

Beta Blocker Therapy in Mild to Moderate Asthmatics

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 4, 2012

Primary Completion Date

May 25, 2013

Study Completion Date

May 25, 2013

Conditions
Asthma
Interventions
DRUG

Propranolol

Propranolol: 10mg bd for 1 week, 20mg bd for 2 weeks, 80mg MR for 4 weeks.

DRUG

Placebo

Placebo tablets: 1 tab bd for 2 weeks, 1 tab od for 4 weeks

DRUG

Qvar 50

Qvar 50, 1 puff bd for 6 weeks

DRUG

Qvar 100

Qvar 100, 2 puffs bd for 6 weeks

Trial Locations (1)

DD1 9SY

Asthma and Allergy Research Group, University of Dundee, Dundee

All Listed Sponsors
collaborator

Chief Scientist Office of the Scottish Government

OTHER_GOV

lead

University of Dundee

OTHER

NCT01544634 - Beta Blocker Therapy in Mild to Moderate Asthmatics | Biotech Hunter | Biotech Hunter